Tricyclic compound

Details Tricyclic compound Tricyclic compound

2007-01-09

2007-01-09

McKenzie, Thomas C. (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S080000, C546S081000

Reexamination Certificate

active

10859098

ABSTRACT:
A novel compound represented by the formula (1):[R1represents hydrogen atom, chlorine atom, or hydroxyl group; X1. . . X2represents—CH(R2)—CH(R3)—, —CH(R2)—CH(R3)—CH(R4)—, etc.; R2to R4represent hydrogen atom, or an alkyl group; A1, A11, A2, and A21represent hydrogen atom, or an alkyl group; Y represents —CH(A3)—, —CH(A3)—C(A4)(A41)—, —CH(A3)—C(A4)(A41)—C(A5)(A51)—, or a single bond; A3, A4, A41, A5, and A51represent hydrogen atom, or an alkyl group; Z represents hydroxyl group, or —N(A6)(A61); A6represents hydrogen atom, or an alkyl group, A61represents hydrogen atom, an alkyl group, an aralkyl group, etc.; and groups in each of one or more combinations selected from the group consisting of combinations of A6and A3, A6and A4, A6and A1, A6and A2, A2and A3, A2and A4, A6and A5, A3and A1, and A5and A1may bind to each other to form a 5- or 6-membered ring], or a salt thereof, which potently inhibits the phosphorylation of myosin regulatory light chain.

REFERENCES:
patent: 6153608 (2000-11-01), Hidaka et al.
patent: 2004/0102437 (2004-05-01), Takami et al.
patent: 0956865 (1999-11-01), None
patent: 1403255 (2004-03-01), None
patent: 1 541 599 (2005-06-01), None
patent: 52-27800 (1977-03-01), None
patent: 54-54140 (1979-04-01), None
patent: 2001-261556 (2001-09-01), None
patent: WO-95/05824 (1995-03-01), None
patent: WO99/20620 (1999-04-01), None
patent: WO 00/09162 (2000-02-01), None
patent: WO 01/68607 (2001-09-01), None
Piantanida et al., “4,9-Diazapyrenium cation. Synthesis, physico-chemical properties and binding of nucleotides in water”, Perkin 2, vol. 2, pp. 375-383.
Barany et al., Biochemistry of Smooth Muscle Contraction, pp. 321-339, (1996).
Kamm et al., Annu. Rev. Physoil., vol. 51, pp. 299-313, (1989).
Schmidt et al., J. Neurobiol., vol. 52, No. 3, pp. 175-188, (2002).
Niggli, V., FEBS Letters, vol. 445, pp. 69-72, (1999).
Kitani et al., Biochem. Biophys. Res. Commun., vol. 183, No. 1, pp. 48-54, (1992).
Itoh et al., Biochem. Biophys. Acta., vol. 1136, pp. 52-56, (1992).
Mills et al., J. Cell Biol., Vol. 140, No. 3, pp. 627-636, (1998).
Suzuki et al., Br. J. Pharmacol., vol. 109, pp. 703-712, (1993).
Howe et al., Biochem. J., vol. 255, pp. 423-429, (1988).
Mobley et al., Exp. Cell Res., vol. 214, pp. 55-66, (1994).
Woodgate et al., Heterocycles, vol. 26, No. 4, pp. 1029-1036, (1987).
Herbert et al., J. Med. Chem., vol. 30, pp. 2081-2086, (1987).

Affiliated with

Also associated with

Rating

Tricyclic compound does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tricyclic compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic compound will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3732626